Relevant and even prescient commentary on news, politics and the economy.

New Way for Consumers to Access Sanofi’s Lantus Diabetes Prescriptions for $35

What is occurring in this announcement is GoodRx working or negotiating with Sanofi to reduce out-of-pocket costs to consumers for Sanofi’s Lantus, a treatment for diabetes. The out of pocket costs will be capped at $35.00. Great cost relief news for people who are not on Medicare, etc. More of the GoodRx announcement below. GoodRx […]